Cargando…
Cancer patients and COVID-19: Mortality, serious complications, biomarkers, and ways forward
The SARS-CoV-2 (COVID-19) pandemic has particularly serious consequences for cancer patients, as they are at high risk for severe complications and mortality due to the virus since cancer patients are immunocompromised. Preliminary evidence suggests that patients with hematological, and metastatic m...
Autores principales: | Gupta, Kush, Gandhi, Shipra, Mebane, Alexander, Singh, Angelica, Vishnuvardhan, Nivetha, Patel, Eshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832265/ https://www.ncbi.nlm.nih.gov/pubmed/33360669 http://dx.doi.org/10.1016/j.ctarc.2020.100285 |
Ejemplares similares
-
Evaluation of Antiplatelet and Anticoagulation Therapy in High-Risk COVID-19 Patients
por: Ashraf, Farah, et al.
Publicado: (2020) -
ABO Blood Type and Outcomes in a Diverse COVID-19 Infected Population
por: Paul, Sonal, et al.
Publicado: (2020) -
Outcomes in COVID-19 Patients on Treatment Dose Anti-Coagulation Compared to Prophylactic Dose Anti-Coagulation
por: Kodama, Rich, et al.
Publicado: (2020) -
The Way Forward
por: Singh, Yamuna
Publicado: (2020) -
Neuro-ophthalmology in India: The way forward
por: Nair, Akshay Gopinathan, et al.
Publicado: (2014)